Related Experiment Videos
Local Stem Cell Therapy for Crohn's Perianal Fistulae
Diana L Franco1, Stefan D Holubar2, Amy L Lightner3
1Center for Inflammatory Bowel Disease, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Inflammatory Bowel Diseases
|December 12, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity.
Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Management and Treatment of Perianal Fistulizing Crohn's Disease.
Clinical and experimental gastroenterology·2025
Emerging Technologies in Inflammatory Bowel Disease: A Minireview on Future Treatment Modalities.
The Surgical clinics of North America·2025
Perianal Fistulizing Crohn's Disease: Outcomes of Surgical Repairs and Current State of Stem Cell-Based Therapies.
Clinics in colon and rectal surgery·2025
The Songdo consensus: Development of minimum reporting standards for studies of intervention in idiopathic anal fistula using a modified nominal group technique.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for amyotrophic lateral sclerosis.
Neurodegenerative disease management·2024
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.
Inflammatory bowel diseases·2026
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.
Inflammatory bowel diseases·2026
Novel proteomic signatures of stricturing Crohn disease using a treatment-naive cohort.
Inflammatory bowel diseases·2026
Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysis.
Inflammatory bowel diseases·2026
Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Association between ineffective health self-management and severe radiodermatitis: Cohort study.
International journal of nursing knowledge·2026
Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.
The British journal of radiology·2026
A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.
Indian journal of ophthalmology·2026